These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


375 related items for PubMed ID: 25169971

  • 21. A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection.
    Suzuki E, Kim S, Cheung HK, Corbley MJ, Zhang X, Sun L, Shan F, Singh J, Lee WC, Albelda SM, Ling LE.
    Cancer Res; 2007 Mar 01; 67(5):2351-9. PubMed ID: 17332368
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
    Li CY, Chen YH, Wang Q, Hou JW, Wang H, Wang YP, Li YG.
    J Hypertens; 2016 Sep 01; 34(9):1766-77. PubMed ID: 27379535
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. p-SMAD2/3 and DICER promote pre-miR-21 processing during pressure overload-associated myocardial remodeling.
    García R, Nistal JF, Merino D, Price NL, Fernández-Hernando C, Beaumont J, González A, Hurlé MA, Villar AV.
    Biochim Biophys Acta; 2015 Jul 01; 1852(7):1520-30. PubMed ID: 25887159
    [Abstract] [Full Text] [Related]

  • 26. Dasatinib Attenuates Pressure Overload Induced Cardiac Fibrosis in a Murine Transverse Aortic Constriction Model.
    Balasubramanian S, Pleasant DL, Kasiganesan H, Quinones L, Zhang Y, Sundararaj KP, Roche S, O'Connor R, Bradshaw AD, Kuppuswamy D.
    PLoS One; 2015 Jul 01; 10(10):e0140273. PubMed ID: 26458186
    [Abstract] [Full Text] [Related]

  • 27. Blockade of PAR-1 Signaling Attenuates Cardiac Hypertrophy and Fibrosis in Renin-Overexpressing Hypertensive Mice.
    Yokono Y, Hanada K, Narita M, Tatara Y, Kawamura Y, Miura N, Kitayama K, Nakata M, Nozaka M, Kato T, Kudo N, Tsushima M, Toyama Y, Itoh K, Tomita H.
    J Am Heart Assoc; 2020 Jun 16; 9(12):e015616. PubMed ID: 32495720
    [Abstract] [Full Text] [Related]

  • 28. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.
    Engebretsen KV, Lunde IG, Strand ME, Waehre A, Sjaastad I, Marstein HS, Skrbic B, Dahl CP, Askevold ET, Christensen G, Bjørnstad JL, Tønnessen T.
    FEBS J; 2013 May 16; 280(10):2382-98. PubMed ID: 23480731
    [Abstract] [Full Text] [Related]

  • 29. Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury.
    Anscher MS, Thrasher B, Zgonjanin L, Rabbani ZN, Corbley MJ, Fu K, Sun L, Lee WC, Ling LE, Vujaskovic Z.
    Int J Radiat Oncol Biol Phys; 2008 Jul 01; 71(3):829-37. PubMed ID: 18411002
    [Abstract] [Full Text] [Related]

  • 30. Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling.
    Shinde AV, Dobaczewski M, de Haan JJ, Saxena A, Lee KK, Xia Y, Chen W, Su Y, Hanif W, Kaur Madahar I, Paulino VM, Melino G, Frangogiannis NG.
    Cardiovasc Res; 2017 Jul 01; 113(8):892-905. PubMed ID: 28371893
    [Abstract] [Full Text] [Related]

  • 31. Cardioprotective effects of lysyl oxidase inhibition against volume overload-induced extracellular matrix remodeling.
    El Hajj EC, El Hajj MC, Ninh VK, Gardner JD.
    Exp Biol Med (Maywood); 2016 Mar 01; 241(5):539-49. PubMed ID: 26582054
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart.
    Herum KM, Lunde IG, Skrbic B, Louch WE, Hasic A, Boye S, Unger A, Brorson SH, Sjaastad I, Tønnessen T, Linke WA, Gomez MF, Christensen G.
    Cardiovasc Res; 2015 May 01; 106(2):217-26. PubMed ID: 25587045
    [Abstract] [Full Text] [Related]

  • 37. A synthetic peptide from transforming growth factor-beta1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats.
    Hermida N, López B, González A, Dotor J, Lasarte JJ, Sarobe P, Borrás-Cuesta F, Díez J.
    Cardiovasc Res; 2009 Feb 15; 81(3):601-9. PubMed ID: 19019833
    [Abstract] [Full Text] [Related]

  • 38. Lansoprazole alleviates pressure overload-induced cardiac hypertrophy and heart failure in mice by blocking the activation of β-catenin.
    Lin H, Li Y, Zhu H, Wang Q, Chen Z, Chen L, Zhu Y, Zheng C, Wang Y, Liao W, Bin J, Kitakaze M, Liao Y.
    Cardiovasc Res; 2020 Jan 01; 116(1):101-113. PubMed ID: 30689763
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Increased myocardial collagen content in transgenic rats overexpressing cardiac angiotensin-converting enzyme is related to enhanced breakdown of N-acetyl-Ser-Asp-Lys-Pro and increased phosphorylation of Smad2/3.
    Pokharel S, van Geel PP, Sharma UC, Cleutjens JP, Bohnemeier H, Tian XL, Schunkert H, Crijns HJ, Paul M, Pinto YM.
    Circulation; 2004 Nov 09; 110(19):3129-35. PubMed ID: 15520311
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 19.